Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000604096 | SCV000728014 | likely benign | not specified | 2018-03-06 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000924784 | SCV001070306 | likely benign | Pitt-Hopkins-like syndrome 2 | 2024-08-31 | criteria provided, single submitter | clinical testing | |
Center for Genomics, |
RCV003224348 | SCV003920302 | uncertain significance | Pitt-Hopkins-like syndrome 2; Chromosome 2p16.3 deletion syndrome | 2021-03-30 | criteria provided, single submitter | clinical testing | NRXN1 NM_001135659 exon 19 p.Thr1165Thr (c.3495A>G): This variant has not been reported in the literature but is present in 2/33456 Latino individuals in the Genome Aggregation Database (http://gnomad.broadinstitute.org/rs757748286). Evolutionary conservation and computational predictive tools for this variant are limited or unavailable. Of note, this variant is a silent variant and does not change the amino acid, reducing the probability that this variant is disease causing. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |